This post was originally published on this site
However, YOU’s shares have plummeted 41.3% in price over the past three months and 42.5% over the past month to close yesterday’s trading session at $26.30. Though the company made significant progress after shifting to biometric screening services to capitalize on the increased travel restrictions during the COVID-19 pandemic, its financials are yet to reflect the benefits of the strategic shift.
In addition, YOU is currently trading at a premium valuation, considering its poor prospects. In terms of its forward EV/Sales, the stock is currently trading at 6.54x, which is 58.1% higher than the 4.13x industry average. Furthermore, YOU’s 7.88x forward Price/Sales is 95.3% higher than the 4.03x industry average. This, along with YOU’s weak profitability, could cause the stock to suffer further price declines in the near term.
